Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...

Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...

Tool is launching its annual Black Friday Mega Sale, offering unbeatable deals. As an industry-leading brand of laser cutters and engravers, xTool embraces the holiday season as a time for creativity ...

at 10:05 Sparrow Pharmaceuticals to Present Two Abstracts at ACR Convergence 2024 and Expand Phase 2 Clinical Trial of Clofutriben with Prednisolone for Polymyalgia Rheumatica to Fifth Cohort Sparrow ...

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...

Those afflicting at least 250 patients were rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis, lupus, Sjögren's syndrome, and polymyalgia rheumatica. RA accounted ...

We have two important LCM opportunities that we'll lead out in 2025 in polymyalgia rheumatica, as well as in giant cell arteritis, both sizable indications that could give us even further ...

He’s the one everyone in the family calls to get free medical advice. Before I even finish my story, he says: “Polymyalgia rheumatica. I’ve had it. Go see your primary care person right now.” ...

Background: Glucocorticoids (GC) are the cornerstone of the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), but they are associated with several adverse events (AEs).

Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. Objectives To evaluate the efficacy and safety of first-line tocilizumab in PMR.